Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Sawitzki

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Trials|August 20, 2025
Randomized adaptive assessment of post COVID syndrome treatments (RAPID): a study protocol for a multicenter, randomized, controlled adaptive platform trial of treatment options for Post Covid Syndrome (PCS) on patients physical function including the first intervention specific appendix RAPID_REVIVE (reducing inflammatory activity in patients with PCS)Lisa Weipert, Ralph G Telgmann, Gabriele Anton, et al.
Transplantation|June 27, 2013
Expansion of memory-type CD8+ T cells correlates with the failure of early immunosuppression withdrawal after cadaver liver transplantation using high-dose ATG induction and rapamycinVincent Donckier, Ligia Craciun, Patrick Miqueu, et al.
Cell Reports. Medicine|August 20, 2025
Rewired type I IFN signaling is linked to age-dependent differences in COVID-19Lev Petrov, Sophia Brumhard, Sebastian Wisniewski, et al.
Nature Cardiovascular Research|February 24, 2025
The cellular and molecular cardiac tissue responses in human inflammatory cardiomyopathies after SARS-CoV-2 infection and COVID-19 vaccinationHenrike Maatz, Eric L Lindberg, Eleonora Adami, et al.
Frontiers in Medicine|July 3, 2023
Fighting Post-COVID and ME/CFS - development of curative therapiesCarmen Scheibenbogen, Judith Theresia Bellmann-Strobl, Cornelia Heindrich, et al.
Science (New York, N.Y.)|September 1, 2021
Cross-reactive CD4<sup>+</sup> T cells enhance SARS-CoV-2 immune responses upon infection and vaccinationLucie Loyal, Julian Braun, Larissa Henze, et al.
The Journal of Clinical Investigation|May 27, 2010
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humansPervinder Sagoo, Esperanza Perucha, Birgit Sawitzki, et al.
Cell|July 4, 2024
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulationRainer Knoll, Elisa T Helbig, Kilian Dahm, et al.
Autoimmunity Reviews|September 24, 2023
Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome - State of the art: Report of the 2nd international meeting at the Charité Fatigue CenterSophie Steiner, Annick Fehrer, Friederike Hoheisel, et al.
Nature|October 25, 2021
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cellsMario Witkowski, Caroline Tizian, Marta Ferreira-Gomes, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Trials|August 20, 2025
Randomized adaptive assessment of post COVID syndrome treatments (RAPID): a study protocol for a multicenter, randomized, controlled adaptive platform trial of treatment options for Post Covid Syndrome (PCS) on patients physical function including the first intervention specific appendix RAPID_REVIVE (reducing inflammatory activity in patients with PCS)Lisa Weipert, Ralph G Telgmann, Gabriele Anton, et al.
Transplantation|June 27, 2013
Expansion of memory-type CD8+ T cells correlates with the failure of early immunosuppression withdrawal after cadaver liver transplantation using high-dose ATG induction and rapamycinVincent Donckier, Ligia Craciun, Patrick Miqueu, et al.
Cell Reports. Medicine|August 20, 2025
Rewired type I IFN signaling is linked to age-dependent differences in COVID-19Lev Petrov, Sophia Brumhard, Sebastian Wisniewski, et al.
Nature Cardiovascular Research|February 24, 2025
The cellular and molecular cardiac tissue responses in human inflammatory cardiomyopathies after SARS-CoV-2 infection and COVID-19 vaccinationHenrike Maatz, Eric L Lindberg, Eleonora Adami, et al.
Frontiers in Medicine|July 3, 2023
Fighting Post-COVID and ME/CFS - development of curative therapiesCarmen Scheibenbogen, Judith Theresia Bellmann-Strobl, Cornelia Heindrich, et al.
Science (New York, N.Y.)|September 1, 2021
Cross-reactive CD4<sup>+</sup> T cells enhance SARS-CoV-2 immune responses upon infection and vaccinationLucie Loyal, Julian Braun, Larissa Henze, et al.
The Journal of Clinical Investigation|May 27, 2010
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humansPervinder Sagoo, Esperanza Perucha, Birgit Sawitzki, et al.
Cell|July 4, 2024
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulationRainer Knoll, Elisa T Helbig, Kilian Dahm, et al.
Autoimmunity Reviews|September 24, 2023
Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome - State of the art: Report of the 2nd international meeting at the Charité Fatigue CenterSophie Steiner, Annick Fehrer, Friederike Hoheisel, et al.
Nature|October 25, 2021
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cellsMario Witkowski, Caroline Tizian, Marta Ferreira-Gomes, et al.
Pageof 14